Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

JNJ

Johnson & Johnson

Apr 15 • 04:00PM ET

147.59

Dollar change +0.07
Percentage change 0.05	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO IVV VTV VIG VYM VHT IWD QUAL DGRO

Scroll to Statements

Index	DJIA, S&P 500	P/E	26.46	EPS (ttm)	5.58	Insider Own	0.16%	Shs Outstand	2.41B	Perf Week	-2.64%
Market Cap	355.51B	Forward P/E	13.39	EPS next Y	11.02	Insider Trans	-1.74%	Shs Float	2.40B	Perf Month	-7.30%
Income	14.17B	PEG	5.51	EPS next Q	2.64	Inst Own	71.47%	Short Float	0.66%	Perf Quarter	-9.11%
Sales	93.02B	P/S	3.82	EPS this Y	7.46%	Inst Trans	-0.39%	Short Ratio	2.22	Perf Half Y	-5.59%
Book/sh	28.57	P/B	5.17	EPS next Y	3.36%	ROA	7.62%	Short Interest	15.94M	Perf Year	-11.15%
Cash/sh	9.52	P/C	15.51	EPS next 5Y	4.80%	ROE	18.57%	52W Range	144.95 - 175.97	Perf YTD	-5.84%
Dividend Est.	4.81 (3.26%)	P/FCF	19.48	EPS past 5Y	-0.27%	ROI	14.80%	52W High	-16.13%	Beta	0.54
Dividend TTM	4.76 (3.23%)	Quick Ratio	0.91	Sales past 5Y	1.31%	Gross Margin	67.94%	52W Low	1.82%	ATR (14)	2.03
Dividend Ex-Date	Feb 16, 2024	Current Ratio	1.16	EPS Y/Y TTM	-17.52%	Oper. Margin	25.66%	RSI (14)	24.03	Volatility	1.37% 1.22%
Employees	131900	Debt/Eq	0.44	Sales Y/Y TTM	-2.10%	Profit Margin	15.23%	Recom	2.30	Target Price	176.33
Option/Short	Yes / Yes	LT Debt/Eq	0.39	EPS Q/Q	25.42%	Payout	84.93%	Rel Volume	1.18	Prev Close	147.52
Sales Surprise	1.78%	EPS Surprise	0.39%	Sales Q/Q	-9.83%	Earnings	Apr 16 BMO	Avg Volume	7.19M	Price	147.59
SMA20	-4.47%	SMA50	-6.14%	SMA200	-7.13%	Trades		Volume	8,490,880	Change	0.05%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$170 → $163
Dec-01-23	Upgrade	UBS	Neutral → Buy	$167 → $180
Oct-05-23	Initiated	RBC Capital Mkts	Outperform	$178
Sep-06-23	Initiated	HSBC Securities	Hold	$175
May-30-23	Resumed	Citigroup	Buy	$185
Mar-29-23	Initiated	UBS	Neutral	$164
Mar-01-23	Initiated	Guggenheim	Neutral	$161
Nov-18-22	Initiated	Credit Suisse	Neutral	$170
Oct-18-22	Initiated	Barclays	Equal Weight	$175
Oct-14-22	Reiterated	BofA Securities	Neutral	$185 → $178
Jun-22-22	Initiated	Daiwa Securities	Outperform
May-23-22	Resumed	SVB Leerink	Outperform	$200
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$173
Mar-16-22	Downgrade	Bernstein	Outperform → Mkt Perform	$180 → $183
Mar-02-22	Resumed	BofA Securities	Neutral	$185
Dec-17-21	Initiated	Goldman	Neutral	$161
Dec-15-21	Reiterated	Citigroup	Buy	$192 → $195
Sep-07-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$187
May-28-21	Resumed	Morgan Stanley	Overweight	$187
Apr-28-20	Downgrade	UBS	Buy → Neutral	$163 → $160

Show Previous Ratings

Apr-15-24 04:46PM	Big Bank earnings, March housing data: What to Watch (Yahoo Finance Video)
02:51PM	WHO warns of falsified cough syrup ingredients seized in Pakistan (Reuters)
10:40AM	Johnson & Johnson Reports Earnings Tuesday. What to Expect. (Barrons.com)
10:06AM	Should You Buy Johnson & Johnson (JNJ) Ahead of Earnings? (Zacks)
09:55AM	CORRECTED-UPDATE 3-Tanzania, Rwanda, Zimbabwe join African recall of J&J cough syrup (Reuters)
08:00AM	Loading…
08:00AM	The Art of Valuation: Discovering Johnson & Johnson's Intrinsic Value (GuruFocus.com)
07:43AM	16 Best Dividend Stocks of All Time (Insider Monkey)
06:50AM	Rwanda joins other African countries in recalling J&J children's cough syrup (Reuters)
03:34AM	Stocks to Watch This Week (Barrons.com)
Apr-14-24 09:30AM	What To Expect in the Markets This Week (Investopedia)
Apr-13-24 07:23PM	UPDATE 1-South Africa recalls J&J's cough syrup sold in six African nations after suspected toxicity (Reuters)
02:47PM	South Africa recalls J&J's cough syrup sold in six African nations after suspected toxicity (Reuters)
Apr-12-24 05:45PM	Johnson & Johnson (JNJ) Stock Moves -0.85%: What You Should Know (Zacks)
04:44PM	Bank earnings, housing, Trump trial: What to Watch Next Week (Yahoo Finance Video)
09:09AM	J&J (JNJ) to Begin Pharma Q1 Earnings Season: What's in Store? (Zacks)
08:00AM	Loading…
08:00AM	5 Dividend Kings That Yield More Than Vanguard's Top Value ETF (Motley Fool)
06:12AM	Shockwave Medical (SWAV) Rose on Strong Financial Results (Insider Monkey)
Apr-11-24 02:05PM	UPDATE 1-Kenya recalls J&J children's cough syrup over suspected toxicity (Reuters)
10:10AM	Kenya recalls J&J children's cough syrup over suspected toxicity (Reuters)
09:15AM	Unlocking Q1 Potential of Johnson & Johnson (JNJ): Exploring Wall Street Estimates for Key Metrics (Zacks)
09:00AM	Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know (Zacks)
Apr-10-24 01:01PM	J&J, Rallybio partner on drug development for rare fetal condition (BioPharma Dive)
12:47PM	The Pharmaceutical Industry Finds Itself At A Historical Crossroads (Benzinga)
11:43AM	Nigeria recalls J&J children's cough syrup over toxic substance (Reuters)
04:57AM	Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy? (Motley Fool)
Apr-09-24 04:08PM	Neutrogena Closing Its Los Angeles Headquarters to Move to New Jersey (WWD)
10:00AM	Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
09:51AM	How's AT&T Handling Things? (Motley Fool)
07:37AM	11 Best Biotech ETFs To Buy (Insider Monkey)
04:21AM	3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade (Motley Fool)
06:06PM	Loading…
Apr-08-24 06:06PM	Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference (Business Wire)
05:50PM	Here's Why Johnson & Johnson (JNJ) Fell More Than Broader Market (Zacks)
11:52AM	Kenvue Revamps Cyber Tools After Spinoff From J&J (The Wall Street Journal)
09:40AM	FDA Expands J&J's (JNJ) Carvykti Label in Multiple Myeloma (Zacks)
09:23AM	Trinity Biotech plc (NASDAQ:TRIB) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:18AM	J&J's (JNJ) $13.1B Shockwave Deal to Boost MedTech Cardio (Zacks)
05:19AM	Can Kenvue (KVUE) Improve Efficiency and Invest In Product Development And Marketing? (Insider Monkey)
03:46AM	2 Dividend Stocks to Buy and Hold Forever (Motley Fool)
Apr-07-24 02:30PM	Here's the $4.7 Trillion Market Nvidia Has Its Eyes on Now (Motley Fool)
Apr-06-24 08:15AM	Can a New CEO Fix Boeing? (Motley Fool)
Apr-05-24 11:54PM	CARVYKTI is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy (PR Newswire)
11:36PM	U.S. FDA approves expanded use of J&J's cancer cell therapy (Reuters)
04:13PM	Johnson & Johnson Ends The Shockwave Rumor Mill With $13.1 Billion Takeover (Investor's Business Daily)
04:13PM	Johnson & Johnson to Buy Shockwave Medical in $13.1 Billion Deal (The Wall Street Journal)
03:27PM	Acquisition Watch: Time to Buy Johnson & Johnson (JNJ) or ShockWave Medical's (SWAV) Stock? (Zacks)
01:10PM	Stocks Soar After Robust Jobs Data; AMD, Amazon.com Lead Tech Rally, But Tesla Sinks On This News (Investor's Business Daily)
12:12PM	Stocks Head Higher After Robust Jobs Data; Meta Platforms Leads Tech Rally, But Tesla Dives On This News (Investor's Business Daily)
11:52AM	J&J Buys Shockwave Medical for $13.1B, Boosting Its Cardiovascular Treatment Portfolio (Investopedia)
11:45AM	Market Rally Under Pressure; Tesla, Humana In Focus: Weekly Review (Investor's Business Daily)
11:07AM	Johnson & Johnson to buy Shockwave in $13.1B deal (Yahoo Finance Video)
10:49AM	Stock Market Heads Higher After Robust Jobs Data; Tech Rally Led By Amazon, AMD, Netflix (Investor's Business Daily)
10:40AM	Johnson & Johnson just bought a second big heart device company (Quartz)
09:59AM	Johnson & Johnson to Buy Shockwave Medical for $13.1 Billion. Its a Cardio Health Play. (Barrons.com)
09:31AM	SWAV Stock Alert: Shockwave Medical Lands Big Buyer in Johnson & Johnson (InvestorPlace)
08:56AM	J&J to pump another $13B into its MedTech business with Shockwave deal (Associated Press Finance)
08:45AM	5 Best Low-Risk Investments in April 2024 (Insider Monkey)
07:24AM	Johnson & Johnson to Buy Shockwave Medical for $13.1 Billion (Barrons.com)
06:41AM	UPDATE 4-J&J boosts heart device business with $12.5 bln Shockwave Medical deal (Reuters)
06:39AM	J&J boosts heart device business with $12.5 billion Shockwave Medical deal (Reuters)
06:36AM	Johnson & Johnson to buy Shockwave Medical in $12.5 bln deal (Reuters)
06:31AM	Johnson & Johnson to Acquire Shockwave Medical (Business Wire)
Apr-04-24 06:01PM	Johnson & Johnson Recommends Shareholders Reject Mini-Tender Offer by TRC Capital Investment Corporation (Business Wire)
05:59PM	J&J recommends shareholders to reject 'mini-tender' offer by TRC Capital Investment (Reuters)
05:55PM	REFILE-J&J recommends shareholders to reject 'mini-tender' offer by TRC Capital Investment (Reuters)
07:30AM	FDA approves new antibiotic for several hard-to-treat infections (BioPharma Dive)
04:05AM	Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake. (Barrons.com)
Apr-03-24 12:10PM	Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report? (Zacks)
11:12AM	Johnson & Johnson CIO says employee upskilling is key to transforming health care (Fortune)
08:48AM	Genmab Buys ProfoundBio for $1.8B to Boost Oncology Portfolio (Investopedia)
05:39AM	Should You Continue to Hold Legend Biotech Corporation (LEGN)? (Insider Monkey)
Apr-02-24 05:45PM	Johnson & Johnson (JNJ) Stock Moves -0.03%: What You Should Know (Zacks)
04:30PM	Johnson & Johnson to Participate in the BofA Securities Health Care Conference (Business Wire)
Apr-01-24 02:01PM	UPDATE 1-Teva, Viatris win new chance to challenge J&J schizophrenia drug patent (Reuters)
11:52AM	Teva, Viatris win new chance to challenge J&J schizophrenia drug patent (Reuters)
08:00AM	Invest with Confidence: Intrinsic Value Unveiled of Johnson & Johnson (GuruFocus.com)
Mar-31-24 11:52AM	Top 12 Dividend Stocks To Buy Now According To Analysts (Insider Monkey)
03:10AM	2024 S&P 500 Bull Market: 2 Unstoppable Growth Stocks to Buy Right Now (Motley Fool)
Mar-30-24 05:19AM	3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade (Motley Fool)
Mar-29-24 12:16PM	25 Things Every Dividend Investor Should Know (Insider Monkey)
09:00AM	Why Shockwave Medical Stock Rallied as Much as 18% Higher This Week (Motley Fool)
09:00AM	Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock (Zacks)
07:39AM	14 Best Stocks To Buy According to AI (Insider Monkey)
05:00AM	Ozempic's cheaper side, weight loss drug competition, and Amazon delivery: Pharma news roundup (Quartz)
Mar-28-24 02:36PM	20 Best Stocks to Buy Right Now According to Financial Media (Insider Monkey)
06:15AM	3 Dividend Stocks That Are Likely to Raise Their Payouts in April (Motley Fool)
Mar-27-24 03:56PM	UPDATE 3-J&J can contest evidence linking its talc to cancer, US judge rules (Reuters)
03:39PM	J&J can contest evidence linking its talc to cancer, US judge rules (Reuters)
03:32PM	J&J gets new opportunity to contest evidence linking talc to cancer (Reuters)
06:41AM	J&J in talks to buy Shockwave Medical: WSJ (MedTech Dive)
Mar-26-24 05:45PM	Why the Market Dipped But Johnson & Johnson (JNJ) Gained Today (Zacks)
05:24PM	Johnson & Johnson is reportedly considering its second big heart device company acquisition (Quartz)
04:24PM	Johnson & Johnson in talks to acquire Shockwave Medical: WSJ (Yahoo Finance Video)
04:15PM	Johnson & Johnson Considers Deal for Shockwave Medical (The Wall Street Journal)
02:33PM	J&J in talks to buy Shockwave Medical, WSJ reports (Reuters)
02:30PM	Shockwave Medical Stock Pops After Journal Reports Johnson & Johnson Interest (The Wall Street Journal)
02:23PM	Johnson & Johnson considers deal for Shockwave Medical, WSJ reports (Reuters)
08:02AM	14 Best Medical Device Stocks To Buy Now (Insider Monkey)
06:18AM	25 Countries with the Highest Death Rate From Malnutrition (Insider Monkey)
06:07AM	25 Countries with Lowest Rates of Infant Mortality (Insider Monkey)
05:15AM	20 Biggest Health Care Companies in Australia, 2024 (Insider Monkey)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Broadhurst Vanessa	EVP, Global Corp Affairs	Mar 13 '24	Sale	162.16	8,891	1,441,765	15,043	Mar 13 04:36 PM
JOHNSON & JOHNSON	10% Owner	Feb 29 '24	Option Exercise	0.72	3,855	2,792	4,103,430	Mar 06 03:42 PM
JOHNSON & JOHNSON	10% Owner	Feb 16 '24	Sale	25.81	3,725	96,142	4,099,575	Mar 06 03:42 PM
Decker Robert J	VP Corporate Controller	Feb 13 '24	Option Exercise	0.00	313	0	19,059	Feb 15 04:53 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 13 '24	Option Exercise	0.00	408	0	24,143	Feb 15 04:53 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 13 '24	Option Exercise	0.00	651	0	8,576	Feb 15 04:53 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 13 '24	Option Exercise	0.00	3,470	0	364,809	Feb 15 04:53 PM
Hait William	See Remarks	Feb 13 '24	Option Exercise	0.00	834	0	39,074	Feb 15 04:53 PM
Fasolo Peter	Exec VP, Chief HR Officer	Feb 13 '24	Option Exercise	0.00	925	0	112,550	Feb 15 04:53 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 13 '24	Option Exercise	0.00	499	0	13,290	Feb 15 04:53 PM
Swanson James D.	EVP, CIO	Feb 13 '24	Option Exercise	0.00	447	0	14,765	Feb 15 04:53 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 13 '24	Option Exercise	0.00	1,302	0	155,517	Feb 15 04:53 PM
Wolk Joseph J	Exec VP, CFO	Feb 13 '24	Option Exercise	0.00	1,780	0	69,663	Feb 15 04:53 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 13 '24	Option Exercise	0.00	651	0	82,599	Feb 15 04:53 PM
Decker Robert J	VP Corporate Controller	Feb 12 '24	Option Exercise	0.00	1,912	0	19,269	Feb 14 06:36 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 12 '24	Option Exercise	0.00	36,618	0	377,239	Feb 14 06:36 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 12 '24	Option Exercise	0.00	26,202	0	167,618	Feb 14 06:36 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 12 '24	Option Exercise	0.00	2,859	0	8,959	Feb 14 06:36 PM
Wolk Joseph J	Exec VP, CFO	Feb 12 '24	Option Exercise	0.00	25,835	0	78,699	Feb 14 06:36 PM
Hait William	See Remarks	Feb 12 '24	Option Exercise	0.00	8,932	0	42,316	Feb 14 06:36 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 12 '24	Option Exercise	0.00	4,701	0	25,081	Feb 14 06:36 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 12 '24	Option Exercise	0.00	13,813	0	89,014	Feb 14 06:36 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 12 '24	Option Exercise	0.00	5,736	0	15,678	Feb 14 06:36 PM
Swanson James D.	EVP, CIO	Feb 12 '24	Option Exercise	0.00	5,456	0	16,013	Feb 14 06:36 PM
Fasolo Peter	Exec VP, Chief HR Officer	Feb 12 '24	Option Exercise	0.00	14,960	0	118,644	Feb 14 06:36 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 09 '24	Option Exercise	90.44	130,969	11,844,836	439,283	Feb 13 05:18 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 09 '24	Option Exercise	90.44	59,397	5,371,865	200,813	Feb 12 07:25 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 09 '24	Sale	156.27	59,397	9,281,969	141,416	Feb 12 07:25 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 08 '24	Option Exercise	0.00	3,739	0	143,329	Feb 12 07:25 PM
Decker Robert J	VP Corporate Controller	Feb 08 '24	Option Exercise	0.00	655	0	17,572	Feb 12 07:24 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 08 '24	Option Exercise	0.00	1,880	0	21,083	Feb 12 07:24 PM
Hait William	See Remarks	Feb 08 '24	Option Exercise	0.00	3,059	0	34,497	Feb 12 07:24 PM
Fasolo Peter	Exec VP, Chief HR Officer	Feb 08 '24	Option Exercise	0.00	2,135	0	104,465	Feb 12 07:24 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 08 '24	Option Exercise	0.00	1,964	0	10,943	Feb 12 07:24 PM
Swanson James D.	See Remarks	Feb 08 '24	Option Exercise	0.00	1,868	0	11,111	Feb 12 07:24 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 08 '24	Option Exercise	0.00	979	0	6,463	Feb 12 07:24 PM
Wolk Joseph J	Exec VP, CFO	Feb 08 '24	Option Exercise	0.00	3,686	0	53,911	Feb 12 07:25 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 08 '24	Option Exercise	0.00	1,971	0	67,905	Feb 12 07:25 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 08 '24	Option Exercise	0.00	5,225	0	310,583	Feb 12 07:25 PM
Hait William	See Remarks	Jul 26 '23	Option Exercise	90.44	14,698	1,329,287	102,445	Jul 27 05:52 PM
Hait William	See Remarks	Jul 26 '23	Sale	172.00	14,698	2,528,056	87,747	Jul 27 05:52 PM
Fasolo Peter	Exec VP, Chief HR Officer	Jul 25 '23	Sale	170.32	20,000	3,406,498	102,696	Jul 27 05:52 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Jun 12 '23	Sale	160.00	12,465	1,994,400	65,934	Jun 14 04:19 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JNJ

Johnson & Johnson

Upgrade your FINVIZ experience